Marinus Pharmaceuticals (NASDAQ:MRNS) Shares Down 6.8%



  • Summary:

     

    Marinus Pharmaceuticals Inc (NASDAQ:MRNS)’s share price traded down 6.8% during mid-day trading on Wednesday . The stock traded as low as $1.08 and last traded at $1.10, 960,300 shares traded hands during trading. An increase of 2% from the average session volume of 938,631 shares. The stock had previously closed at $1.18.

    Several equities research analysts recently issued reports on the stock. ValuEngine cut shares of Marinus Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. Zacks Investment Research cut shares of Marinus Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Tuesday, November 12th. LADENBURG THALM/SH SH reiterated a “buy” rating and set a $5.00 price target on shares of Marinus Pharmaceuticals ...

     

     

    Read Full News: https://darbydigitalnews.com/latest-news/marinus-pharmaceuticals-nasdaqmrns-shares-down-6-8/147339.html


Log in to reply